CABS2024专题讲座：Clinical Development Highlights.
CABS - Science & Technolog Committee 隆重推出2024专题讲座：Clinical Development Highlights.
时间：4/27/24, Saturday;
地点：1633 Old Bayshore Hwy #280, Burlingame, CA 94010
注册：https://www.cabsweb.org/registration/56 ... ighlights/
非常期待大家的参加！
旧金山湾区下周CABS2024专题讲座：Clinical Development Highlights.
版主： Tlexander
-
Tlexander楼主
- 论坛点评
- 帖子： 2995
- 注册时间： 7月 22, 2022, 5:34 pm
#1 旧金山湾区下周CABS2024专题讲座：Clinical Development Highlights.
上次由 Tlexander 在 4月 22, 2024, 2:31 am，总共编辑 1 次。
原因： 未提供修改原因
原因： 未提供修改原因
-
Tlexander楼主
- 论坛点评
- 帖子： 2995
- 注册时间： 7月 22, 2022, 5:34 pm
#2 Re: 旧金山湾区下周CABS2024专题讲座：Clinical Development Highlights.
1. Aris Persidis, Ph.D.
- President and Co-Founder of Biovista Inc., a bioinformatics company focused on drug repurposing.
- Pioneered the use of computational approaches for drug discovery and development.
2. Pauline C. Ng, Ph.D.
- Vice President and Global Head of Computational Biology at GlaxoSmithKline (GSK).
- Led the development of computational platforms and strategies for target identification, lead optimization, and biomarker discovery.
3. Søren Brunak, Ph.D.
- Professor of Disease Systems Biology at the University of Copenhagen and former Head of Computational Biology at Novo Nordisk.
- Contributed to the development of bioinformatics tools and methods for drug discovery, particularly in metabolic disorders and protein engineering.
4. Isidore Rigoutsos, Ph.D.
- Co-Founder and CEO of Tyme Technologies, a biotechnology company focused on cancer metabolism-based therapies.
- Developed computational approaches for identifying novel therapeutic targets and biomarkers in cancer.
5. Greg Michaelson, Ph.D.
- Vice President of Computational Biology at Agios Pharmaceuticals.
- Led the development of computational platforms for target identification and drug discovery in the areas of cancer metabolism and rare genetic diseases.
6. Maricel Kann, Ph.D.
- Senior Director of Computational Biology at Amgen.
- Focused on applying machine learning and artificial intelligence techniques to drug discovery and development processes.
7. Christopher Bouton, Ph.D.
- Vice President of Computational Biology at Moderna Therapeutics.
- Led the development of computational platforms for mRNA design, optimization, and delivery for therapeutic applications.
8. Aidan Fennelly, Ph.D.
- Vice President of Computational Biology at Danaher Corporation.
- Contributed to the development of bioinformatics tools and strategies for biomarker discovery and precision medicine.
- President and Co-Founder of Biovista Inc., a bioinformatics company focused on drug repurposing.
- Pioneered the use of computational approaches for drug discovery and development.
2. Pauline C. Ng, Ph.D.
- Vice President and Global Head of Computational Biology at GlaxoSmithKline (GSK).
- Led the development of computational platforms and strategies for target identification, lead optimization, and biomarker discovery.
3. Søren Brunak, Ph.D.
- Professor of Disease Systems Biology at the University of Copenhagen and former Head of Computational Biology at Novo Nordisk.
- Contributed to the development of bioinformatics tools and methods for drug discovery, particularly in metabolic disorders and protein engineering.
4. Isidore Rigoutsos, Ph.D.
- Co-Founder and CEO of Tyme Technologies, a biotechnology company focused on cancer metabolism-based therapies.
- Developed computational approaches for identifying novel therapeutic targets and biomarkers in cancer.
5. Greg Michaelson, Ph.D.
- Vice President of Computational Biology at Agios Pharmaceuticals.
- Led the development of computational platforms for target identification and drug discovery in the areas of cancer metabolism and rare genetic diseases.
6. Maricel Kann, Ph.D.
- Senior Director of Computational Biology at Amgen.
- Focused on applying machine learning and artificial intelligence techniques to drug discovery and development processes.
7. Christopher Bouton, Ph.D.
- Vice President of Computational Biology at Moderna Therapeutics.
- Led the development of computational platforms for mRNA design, optimization, and delivery for therapeutic applications.
8. Aidan Fennelly, Ph.D.
- Vice President of Computational Biology at Danaher Corporation.
- Contributed to the development of bioinformatics tools and strategies for biomarker discovery and precision medicine.